Product Information
HUMULIN 70/30 KWIKPEN is a brand product labeled by Eli Lilly and Company, priced at $9.0345 per ML under NDC 00002880359. Its NADAC has been published 640 times since Mar 26, 2014.
Strength
100 [iU]/mL
Manufacturer
Eli Lilly and CompanyNDC
00002880359
Classification
Brand
Dosage Form
INJECTION, SUSPENSION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
INSULIN HUMANApproval Type
Biologic (BLA)
FDA Application
BLA019717On Market Since
11/7/2013
Pharmacological Classes
Price Statistics
The NADAC for HUMULIN 70/30 KWIKPEN has been published 640 times since Mar 26, 2014, and over the history we have for it it has declined 51.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.0345 per ML |
|---|---|
| All-time high | $30.6433 (Jan 16, 2019) |
| All-time low | $9.0250 (Jan 10, 2024) |
| 52-week high | $9.0412 |
| 52-week low | $9.0345 |
| Median price | $30.1547 |
| Average price | $24.5894 |
| Largest weekly change | -70.0% (Jan 10, 2024) |
| Weeks tracked | 640 |
| Tracking since | Mar 26, 2014 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 53% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HUMULIN 70/30 KWIKPEN?
The current National Average Drug Acquisition Cost (NADAC) for HUMULIN 70/30 KWIKPEN, manufactured by Eli Lilly and Company, is $9.0345 per ML (NDC 00002880359), effective Jun 24, 2026.
How has the price of HUMULIN 70/30 KWIKPEN changed over time?
Over the history we have for it, the NADAC for HUMULIN 70/30 KWIKPEN has declined 51.9%. It has been tracked across 640 weekly CMS publications since Mar 26, 2014.
What are the highest and lowest recorded NADAC prices for HUMULIN 70/30 KWIKPEN?
Since Mar 26, 2014, the NADAC for HUMULIN 70/30 KWIKPEN has ranged from a low of $9.0250 (Jan 10, 2024) to a high of $30.6433 (Jan 16, 2019), with a median of $30.1547 per ML.
Are there cheaper alternatives to HUMULIN 70/30 KWIKPEN?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, HUMULIN 70-30 VIAL, is $4.2597 per ML — about 53% below HUMULIN 70/30 KWIKPEN.
Who manufactures HUMULIN 70/30 KWIKPEN?
HUMULIN 70/30 KWIKPEN (NDC 00002880359) is labeled by Eli Lilly and Company, and CMS classifies it as a brand product.
Related Drugs
Same classification